OSUR
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
P/B suggests undervaluation, but the lack of earnings removes traditional valuation anchors.
- P/B of 0.67 suggests asset undervaluation
- Negative earnings make P/E irrelevant
Severe contraction in both top and bottom lines indicates a failing growth trajectory.
- -28.5% Revenue Growth
- -216.7% EPS Growth
Long-term value destruction despite short-term technical bounces.
- Recent 1Y price recovery (+10.6%)
- -67.6% 5Y return
The balance sheet is the only strong pillar of the company.
- Low Debt/Equity
- High Current Ratio
- Piotroski F-Score 6/9
Non-dividend paying stock.
- No dividend payments
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for OSUR and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
OSUR
OraSure Technologies, Inc.
Primary
|
-67.6% | -52.3% | +10.6% | +5.9% | +3.5% | +5.2% |
|
MDWD
MediWound Ltd.
Peer
|
-51.4% | +35.6% | +6.4% | -3.1% | +6.5% | +6.8% |
|
MGNX
MacroGenics, Inc.
Peer
|
-88.9% | -46.5% | +173.2% | +111.6% | +15.7% | +9.1% |
|
CVRX
CVRx, Inc.
Peer
|
-70.1% | -7.4% | -27.5% | -4.1% | +6.5% | -11.5% |
|
LUCD
Lucid Diagnostics Inc.
Peer
|
-89.1% | -5.9% | +7.6% | +8.5% | -6.6% | +13.3% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
OSUR
OraSure Technologies, Inc.
|
BEARISH | $223.97M | - | -18.3% | -59.8% | $3.24 | |
|
MDWD
MediWound Ltd.
|
BEARISH | $226.84M | - | -63.9% | -140.8% | $17.65 | Compare |
|
MGNX
MacroGenics, Inc.
|
BEARISH | $220.55M | - | -86.9% | -49.9% | $3.47 | Compare |
|
CVRX
CVRx, Inc.
|
BEARISH | $220.23M | - | -96.6% | -94.1% | $8.37 | Compare |
|
LUCD
Lucid Diagnostics Inc.
|
BEARISH | $218.06M | - | -710.6% | -% | $1.28 | Compare |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-26 | BOYD STEVEN KYLE | Director | Stock Award | 5,246 | $16,249 |
| 2026-03-20 | MCGRATH KENNETH J | Chief Financial Officer | Purchase | 32,300 | $94,600 |
| 2026-03-20 | EGLINTON MANNER CARRIE | Chief Executive Officer | Purchase | 32,300 | $94,597 |
| 2026-03-13 | MCGRATH KENNETH J | Chief Financial Officer | Purchase | 22,021 | $66,030 |
| 2026-03-13 | EGLINTON MANNER CARRIE | Chief Executive Officer | Purchase | 22,022 | $66,033 |
| 2026-03-02 | MCGRATH KENNETH J | Chief Financial Officer | Stock Award | 115,162 | - |
| 2026-03-02 | EGLINTON MANNER CARRIE | Chief Executive Officer | Stock Award | 484,496 | - |
| 2026-03-02 | ANTHONY MICHELE MARIE | Officer | Stock Award | 57,165 | - |
| 2025-12-17 | KENNY JOHN P | Director | Stock Award | 10,286 | $25,304 |
| 2025-11-28 | GAGLIANO NANCY J | Director | Purchase | 2,100 | $4,982 |
| 2025-10-28 | BOYD STEVEN KYLE | Director | Stock Award | 34,632 | - |
Wall Street Analysts
Professional analyst ratings and price targets
Past News Coverage
Recent headlines mentioning OSUR from our newsroom.